Join thousands of biotech and life science leaders in our community
Welcome to
NewYorkBIO
Upcoming Events
09 Dec 2024 | 10:00 AM - 06:30 PM
The New York Stock Exchange ...
NewYorkBIO has partnered with NYSE to bring together New York's financial community and life science focused companies developing solutions and treatments that will revolutionize patient care.
Latest News
Communications
Governor Hochul announces a new State-of-the-Art Cell and Gene Therapy Hub on Long Island,…
10/22/2024
Communications
FT US PHARMA AND BIOTECH SUMMIT
May 16, 2024
…
FT US PHARMA AND BIOTECH SUMMIT
May 16, 2024
…
04/16/2024
Communications
Composed of accomplished leaders across the life science industry, together they will support…
01/25/2024
Communications
NewYorkBIO Board Member Annette Bakker's op-ed published in BioSpace discussing…
01/16/2024
Join Thousands
Latest Jobs
Management, Marketing | New York
The Medical Science Liaison role is a technically guided sales role within hospitals and similar settings and is responsible for leading the promotion and sale of…
Non-Profit | New York
The New York Stem Cell Foundation (NYSCF) Research Institute is a growing and successful nonprofit whose mission is to accelerate cures for the diseases of our time…
Economic Analyst | New York
The New York Stem Cell Foundation (NYSCF) Research Institute is a growing and successful nonprofit whose mission is to accelerate cures for the diseases of our time…
Non-Profit | New York
NYSCF is seeking an Associate Scientist to join the Immunology team. This position reports directly to the Principal Scientist, Immunology, and works closely with…
StatNews 11/20/2024
Kura Oncology has signed a global partnership with Japanese drugmaker Kyowa Kirin to develop and ...
11/20/2024
Kennedy, who lacks a background in science or public health, appears intent on remaking the FDA ...
11/20/2024
Silence Therapeutics presented what seemed like positive data on zerlasiran, its experimental drug ...
11/20/2024
Ramy Farid of Schrödinger maintains that AI drug discovery won't work unless physics-based ...
11/19/2024
While RFK Jr. has been a vocal critic of pharma, industry executives are shrugging off potential ...
11/19/2024
The FDA rejected an application from Astellas seeking to change the prescribing label for its eye ...
11/19/2024
.@nes047 and @NathanielEDavid formed Jupiter Bioventures to quickly test out, and if necessary ...
11/18/2024
In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, ...
11/18/2024
The pill, called Revuforj, is the first medicine in a class of drugs called menin inhibitors to ...